[18F]FP-R01-MG-F2
IRB Protocol: 40450
Phase 1 small_molecule completed
Quick answer
[18F]FP-R01-MG-F2 for Idiopathic Pulmonary Fibrosis is a Phase 1 program (small_molecule) at PLIANT THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PLIANT THERAPEUTICS, INC.
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed